galantamine and atropine

galantamine has been researched along with atropine in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-199013 (40.63)18.7374
1990's0 (0.00)18.2507
2000's11 (34.38)29.6817
2010's7 (21.88)24.3611
2020's1 (3.13)2.80

Authors

AuthorsStudies
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Curtis, MA; Lin, SX; Sperry, J1
Kozarev, I; Tashev, T1
Vinogradova, VM1
Schmidt, J; Wolf, H1
Baraka, A; Cozanitis, DA; Karhunen, P; Nuuttila, K1
Il'iuchenok, RIu; Vol'f, NV1
Cozanitis, DA; Toivakka, E1
Ilyutchenok, RY; Zinevich, VS1
Gumulka, W; Kostowski, W1
Irmis, F; Klingberg, F; Pickenhain, L1
Wislicki, L1
Fedorov, VI1
STOYANOV, E; VULCHANOVA, S1
STOJANOV, EA1
Getova, DP; Krustev, AD; Sirakov, VN; Turiiski, VI1
Bermudez, I; Groot-Kormelink, PJ; Smulders, CJ; van Kleef, RG; Vijverberg, HP; Zwart, R1
Disterhoft, JF; Oh, MM; Power, JM; Wu, WW1
Badia, A; Camps, P; Clos, MV; Muñoz-Torrero, D; Roman, S1
Adler, M; Albuquerque, EX; Aracava, Y; Fawcett, WP; Hamilton, TA; Kan, RK; Oliveira, M; Pereira, EF; Randall, WR; Romano, JA1
Kellar, KJ1
Albuquerque, EX; Lopes, C; Njar, V; Pereira, EF; Purushottamachar, P; Schwarcz, R; Wu, HQ1
Clark, MG; Finneran, K; Hilmas, CJ; Poole, MJ; Williams, PT1
Akkerman, M; Albuquerque, EX; Alkondon, M; Aracava, Y; Merchenthaler, I; Pereira, EF1
Nezhinskaya, GI; Sapronov, NS; Vladykin, AL1
Acharya, J; Dubey, DK; Golime, R; Palit, M1

Reviews

2 review(s) available for galantamine and atropine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Pyridine alkaloids with activity in the central nervous system.
    Bioorganic & medicinal chemistry, 2020, 12-15, Volume: 28, Issue:24

    Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic

2020

Trials

2 trial(s) available for galantamine and atropine

ArticleYear
Changes in cardiac rhythm with galanthamine hydrobromide.
    Der Anaesthesist, 1973, Volume: 22, Issue:10

    Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atropine; Blood Pressure; Carbon Dioxide; Drug Combinations; Electrocardiography; Female; Galantamine; Heart; Heart Rate; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Oxygen

1973
A comparative study of galanthamine hydrobromide and atropine-neostigmine in conscious volunteers.
    Der Anaesthesist, 1971, Volume: 20, Issue:11

    Topics: Adult; Atropine; Blood Glucose; Blood Pressure; Cholinesterase Inhibitors; Electroencephalography; Eosinophils; Female; Galantamine; Heart Rate; Humans; Leukocyte Count; Neostigmine; Time Factors

1971

Other Studies

28 other study(ies) available for galantamine and atropine

ArticleYear
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
[Experimental and clinical research on the antidote properties of nivalin in acute atropine poisoning].
    Vutreshni bolesti, 1985, Volume: 24, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Animals; Antidotes; Atropine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Female; Galantamine; Guinea Pigs; Humans; Lethal Dose 50; Male

1985
[The role of cholinergic processes in the synaptic transmission in the brain cortex].
    Doklady Akademii nauk SSSR, 1967, Jul-11, Volume: 175, Issue:2

    Topics: Action Potentials; Animals; Atropine; Cerebral Cortex; Galantamine; Parasympatholytics; Parasympathomimetics; Rabbits; Synapses; Synaptic Transmission

1967
[Influence of atropine and cholinesterase inhibitors on brain potentials caused by dental pulp stimulation].
    Acta biologica et medica Germanica, 1972, Volume: 29, Issue:4

    Topics: Animals; Atropine; Brain; Cholinesterase Inhibitors; Dental Pulp; Electric Stimulation; Evoked Potentials; Female; Galantamine; Isoflurophate; Male; Paraoxon; Physostigmine; Rabbits

1972
[Effect of amizil and atropine on hippocampal-amygdaloid evoked potentials].
    Farmakologiia i toksikologiia, 1972, Volume: 35, Issue:4

    Topics: Amygdala; Animals; Atropine; Benactyzine; Cats; Electric Stimulation; Evoked Potentials; Galantamine; Hippocampus

1972
Short latency reticulocortical potentials: effect of muscarinic anticholinergic drugs.
    Neuropharmacology, 1970, Volume: 9, Issue:5

    Topics: Action Potentials; Animals; Atropine; Benactyzine; Cats; Cholinesterase Inhibitors; Dendrites; Electric Stimulation; Galantamine; Mesencephalon; Parasympatholytics; Parasympathomimetics; Peripheral Nerves; Reticular Formation; Synapses

1970
Note on the ganglionic and central actions of galantamine.
    International journal of neuropharmacology, 1968, Volume: 7, Issue:1

    Topics: Acetylcholine; Animals; Atropine; Benactyzine; Cats; Cerebral Cortex; Electroencephalography; Evoked Potentials; Galantamine; Ganglia, Autonomic; Hexamethonium Compounds; Hippocampus; Phenobarbital; Physostigmine; Stimulation, Chemical; Tubocurarine

1968
[The effect of prothiadene and atropine on nivaline induced electrobiological and behavioral changes].
    Activitas nervosa superior, 1967, Volume: 9, Issue:1

    Topics: Animals; Atropine; Behavior, Animal; Electrophysiology; Galantamine; Higher Nervous Activity; Hippocampus; Rats; Tranquilizing Agents

1967
Nivalin (galanthamine hydrobromide), an additional decurarizing agent. Some introductory observations.
    British journal of anaesthesia, 1967, Volume: 39, Issue:12

    Topics: Adolescent; Adult; Anticholesteremic Agents; Atropine; Blood Pressure; Female; Galantamine; Heart Rate; Humans; Male; Middle Aged; Muscles; Neostigmine; Salivation

1967
[Effect of parasympathetic agents on renin secretion in vitro].
    Biulleten' eksperimental'noi biologii i meditsiny, 1984, Volume: 97, Issue:3

    Topics: Animals; Atropine; Diphenylacetic Acids; Galantamine; Ganglionic Blockers; Hexamethonium Compounds; In Vitro Techniques; Kidney Cortex; Neostigmine; Parasympatholytics; Parasympathomimetics; Pilocarpine; Pyrrolizidine Alkaloids; Quaternary Ammonium Compounds; Quinuclidines; Rats; Renin

1984
THE CLINICAL APPLICATION OF NIVALIN AS AN ANTIDOTE OF CURARE.
    Nauchni trudove na Visshiia meditsinski institut, Sofiia, 1963, Volume: 42

    Topics: Adjuvants, Anesthesia; Antidotes; Atropine; Curare; Galantamine; Humans; Neuromuscular Nondepolarizing Agents; Postoperative Care; Toxicology

1963
[GALANTHAMINUM HYDROBROMICUM ("NIVALINE"), A NEW ANTIDOTE OF NON-POLARIZING MUSCLE RELAXANTS. PHARMACOLOGY AND CLINICAL USE].
    Der Anaesthesist, 1964, Volume: 13

    Topics: Anesthesia; Anesthesiology; Animals; Antidotes; Atropine; Biomedical Research; Bradycardia; Cats; Galantamine; Mice; Muscle Relaxants, Central; Neostigmine; Neuromuscular Nondepolarizing Agents; Pharmacology; Rabbits; Rats

1964
In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract.
    European journal of pharmacology, 2004, Sep-13, Volume: 498, Issue:1-3

    Topics: Animals; Atropine; Cholinergic Antagonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Duodenum; Galantamine; Gastrointestinal Motility; Gastrointestinal Tract; Ileum; In Vitro Techniques; Ipratropium; Jejunum; Male; Methysergide; Muscle Contraction; Muscle, Smooth; Peristalsis; Radiography; Rats; Rats, Wistar; Stomach

2004
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
    European journal of pharmacology, 2005, Feb-21, Volume: 509, Issue:2-3

    Topics: Acetylcholine; Alkaloids; Animals; Atropine; Azocines; Binding, Competitive; Cholinergic Agents; Cholinesterase Inhibitors; Dichlorvos; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Membrane Potentials; Models, Biological; Nicotine; Oocytes; Phenylcarbamates; Physostigmine; Plasmids; Quinolizines; Receptors, Nicotinic; Rivastigmine; Scopolamine; Tacrine; Xenopus laevis

2005
Galantamine increases excitability of CA1 hippocampal pyramidal neurons.
    Neuroscience, 2006, Volume: 137, Issue:1

    Topics: Action Potentials; Aging; Animals; Atropine; Bungarotoxins; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Female; Galantamine; Hippocampus; Muscarinic Antagonists; Nicotinic Antagonists; Organ Culture Techniques; Patch-Clamp Techniques; Pyramidal Cells; Rabbits; Receptors, Muscarinic; Receptors, Nicotinic; Synaptic Transmission

2006
Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
    Brain research, 2005, Nov-09, Volume: 1061, Issue:2

    Topics: Acetylcholine; Alkaloids; Aminoquinolines; Animals; Atropine; Cholinesterase Inhibitors; Dopamine Antagonists; Dose-Response Relationship, Drug; Galantamine; Haloperidol; Heterocyclic Compounds, 4 or More Rings; In Vitro Techniques; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Parasympatholytics; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sesquiterpenes

2005
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Aug-29, Volume: 103, Issue:35

    Topics: Acetylcholinesterase; Alkaloids; Animals; Atropine; Behavior, Animal; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Lethal Dose 50; Neurons; Organophosphate Poisoning; Organophosphorus Compounds; Paraoxon; Poisoning; Pyridostigmine Bromide; Sarin; Sesquiterpenes; Soman; Time Factors

2006
Overcoming inhibitions.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Sep-05, Volume: 103, Issue:36

    Topics: Acetylcholine; Acetylcholinesterase; Animals; Atropine; Benzodiazepines; Blood-Brain Barrier; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Neurons; Neurotransmitter Agents; Organophosphate Poisoning; Organophosphates; Organophosphorus Compounds; Paraoxon; Pralidoxime Compounds; Pyridostigmine Bromide; Receptors, Cholinergic; Receptors, Muscarinic; Sarin; Seizures; Soman; Time Factors

2006
Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:1

    Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Atropine; Cells, Cultured; Choline; Corpus Striatum; Dopamine; Galantamine; Kynurenic Acid; Male; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic

2007
Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
    Toxicology and applied pharmacology, 2009, Oct-15, Volume: 240, Issue:2

    Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Erythrocytes; Galantamine; Guinea Pigs; Male; Muscle Fatigue; Muscle Tonus; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Paralysis; Phrenic Nerve; Pralidoxime Compounds; Seizures; Time Factors

2009
Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning.
    Journal of molecular neuroscience : MN, 2010, Volume: 40, Issue:1-2

    Topics: Acetylcholinesterase; Animals; Atropine; Brain; Chemical Warfare Agents; Cholinergic Fibers; Cholinesterase Inhibitors; Cholinesterase Reactivators; Drug Interactions; Female; Galantamine; Guinea Pigs; Lethal Dose 50; Male; Muscarinic Antagonists; Nerve Degeneration; Organ Culture Techniques; Organophosphate Poisoning; Organophosphorus Compounds; Sarin; Soman; Treatment Outcome

2010
Effects of cholinergic agonists and antagonists under conditions of spleen denervation in rats with endotoxic shock.
    Bulletin of experimental biology and medicine, 2010, Volume: 149, Issue:5

    Topics: Animals; Atropine; Cholinergic Agonists; Denervation; Galantamine; Glycerylphosphorylcholine; Heart Rate; Ipratropium; Lipopolysaccharides; Male; Muscarinic Antagonists; Nicotinic Agonists; Rats; Rats, Wistar; Salmonella typhi; Serotonin; Shock, Septic; Spleen

2010
Neuroprotective Effects of Galantamine on Nerve Agent-Induced Neuroglial and Biochemical Changes.
    Neurotoxicity research, 2018, Volume: 33, Issue:4

    Topics: Acetylcholinesterase; Animals; Atropine; Brain; Brain-Derived Neurotrophic Factor; Galantamine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Muscarinic Antagonists; Nerve Agents; Neuroglia; Neuroprotective Agents; Protein Carbonylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; RNA, Messenger; S100 Calcium Binding Protein beta Subunit; Soman; Time Factors

2018